Dental implants and abutments account for most of the market while tools and instruments to support implantation account for just a small part. Following positive developments in 2011, the market contracted in the low-single digit range in 20122. The global market is valued at about CHF 3 billion.
The dental implant market can be divided into ‘premium’, ‘value’ and ‘discount’ segments. Straumann is a leading premium player in the industry and offers a wide range of implants priced at multiple levels within this category.
The five leading multinational manufacturers account for approximately two thirds of the global implant market and pursue premium strategies. The remainder of the market is very fragmented, consisting of several hundred competitors, the majority of which have a local country or regional focus.
Despite the difficult economy and currency effects Straumann managed to build its lead over peer competitors. Current estimates put our share of the global market for implant dentistry at about 18%.2 The difference compared to 2011 is mainly due to currency effects.
The market for CADCAM dentistry, in which Straumann also competes, comprises prosthetic elements (crowns, inlays, onlays, bridges) and equipment (e.g. scanners and milling units). Collectively these generated global revenues of around CHF 2 billion in 2012.3
More than 20%3 of all prosthetic elements (toothborne and implant-borne) were produced by CADCAM in 2012. Although the majority of prosthetic elements are still made by hand, the share of dentists using CADCAM prosthetic elements continues to increase.
‘CADCAM equipment’ breaks down into the following categories:
According to our estimates, more than two thirds of all CADCAM systems sold in 2012 were either full inlab systems or in-lab scanners connected to an offsite milling center.
We have been active in the in-lab scanner (and software) segment since 2007. In 2010, we began to distribute iTero intra-oral scanners in Europe and subsequently the US. In late 2012, we discontinued the distribution of IOS scanners and focused further on enabling digital workflow solutions.
The lack of reliable market data makes it difficult to provide precise information on market shares in restorative dentistry. We estimate that our share of the market for CADCAM elements produced by centralized milling was below 5% in 2012 and our share of the CADCAM equipment market is thought to be lower than 20%.5
The market for oral tissue regeneration products (‘regeneratives’) showed little – if any – growth in 2012 and was estimated to be worth around CHF 400 million6.
The market for regeneratives comprises the following segments:
Straumann is active in all three segments.
1 Straumann estimates, based on Millennium Research Group and iData, including the following countries: Australia, Belgium, Brazil, Canada, China, Czech Republic, France, Germany, Hungary, India, Israel, Italy, Japan, Luxembourg, Netherlands, Poland, Romania, Russia, South Korea, Spain, Sweden, Switzerland, United Kingdom and the United States.
2 According to 2012 FX Rates. Straumann estimates based on MRG , iData and Industry Sources.
3 Including the countries: France, Germany, Italy, Japan, United Kingdom and the United States. According to 2012 FX Rates. Straumann estimates based on MRG , iData and Industry Sources. CADCAM elements include C&B only.
4 United Kingdom and the United States. According to 2012 FX rates. Straumann estimates based on MRG , iData and Straumann proprietary study conducted by KeyStone Research
5 Including the countries: France, Germany, Italy, Japan, United Kingdom and the United States. According to 2012 FX Rates. Straumann estimates based on MRG and iData
6 Including the countries: Australia, France, Germany, Italy, Japan, South Korea, Spain, Sweden, Switzerland, United Kingdom and the United States. According to 2012 FX Rates. Straumann estimates based on MRG and iData
7 Straumann estimates based on MRG and iData